Filter
686
Filtered Results: 686
Text search:
Corticosteroids
Featured
Recommendations
114
New Publications
134
Language
Document type
No document type
311
Guidelines
226
Studies & Reports
73
Manuals
27
Fact sheets
19
Strategic & Response Plan
15
Training Material
7
Brochures
3
Resource Platforms
2
Infographics
2
Situation Updates
1
Countries / Regions
India
59
Global
34
Brazil
25
South Africa
22
Kenya
19
Ethiopia
19
Africa
18
Latin America and the Carribbean
18
Mozambique
14
Argentina
14
Paraguay
12
Tanzania
11
Western and Central Europe
11
Russia
11
Nepal
8
Malawi
8
Zambia
8
Nigeria
7
Cambodia
7
Bangladesh
7
Angola
7
Rwanda
6
Philippines
6
West and Central Africa
6
Ghana
5
Zimbabwe
5
Guinea-Bissau
5
Spain
5
Eastern Europe
5
Eswatini/ Swaziland
5
Colombia
4
Ukraine
4
Germany
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Uganda
4
Indonesia
4
Liberia
4
Ecuador
4
Myanmar / Burma
4
Sierra Leone
3
Senegal
3
USA
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Bolivia
3
Namibia
3
El Salvador
2
Lesotho
2
Syria
2
Burkina Faso
2
Haiti
2
Venezuela
2
North Macedonia
1
Thailand
1
Benin
1
Gambia
1
China
1
Iran
1
Albania
1
Fiji
1
Laos
1
Dominican Republic
1
South–East Asia Region
1
France
1
Southern Africa
1
Vietnam
1
Egypt
1
Yemen
1
Honduras
1
Bhutan
1
Botswana
1
South Sudan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
110
Public Health
53
Women & Child Health
30
Key Resources
9
Capacity Building
3
Pharmacy & Technologies
1
Toolboxes
COVID-19
146
TB
74
NCDs
52
NTDs
31
Pharmacy
27
HIV
26
Rapid Response
18
AMR
15
Caregiver
13
Mental Health
9
Ebola & Marburg
7
Specific Hazards
4
Refugee
4
Conflict
3
Health Financing Toolbox
2
Zika
2
Natural Hazards
1
Disability
1
Planetary Health
1
Polio
1
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
Operational Guidelines
The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from the IPCRG provides guidance on when to start, adjust, or discontinue ICS in COPD treatment. It highlights the benefits and risks, emphasizing personalized...
In the European Union, over 20 million people suffer from asthma. During the 1990s there was a rapid decrease in asthma mortality, probably related to the increased use of inhaled corticosteroids (ICS). However, during the last decade, asthma mortality rates have plateaued, and a consistently high p...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as asthma, osteoporosis, and diabetes, and offers guida...
The article "Asthma treatment in children: A guide to screening for and management of hypothalamic-pituitary-adrenal axis suppression" discusses the risks associated with the use of corticosteroids in pediatric asthma treatment. It highlights that prolonged corticosteroid use can suppress the hypoth...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Africa Centers for Disease Control and Prevention (Africa CDC) está ciente dos comunicados de imprensa sobre os resultados preliminares de um grande ensaio clínico aleatório realizado no Reino Unido, que incluía dexametasona, um corticosteróide, como um dos medicamentos utilizados para o tratam...
Les Centres africains de contrôle et de prévention des maladies (Africa CDC) ont pris connaissance des communiqués de presse concernant les résultats préliminaires d'un vaste essai clinique randomisé mené au Royaume-Uni, qui incluait la dexaméthasone, un corticostéroïde, parmi les médicam...
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patien...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of medi...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
The2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group was coordinated and supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Healt...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
